Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Gallium Ga 68-labeled PSMA-11 PET/CT Imaging for Prostate Cancer

Prostate Cancer Epidemiology

Prostate Cancer and Exercise

The International Prostate Symptoms Score (IPSS)

What is Prostatitis?

Life after prostate cancer treatment

Types of PSA Test

What is benign prostatic hyperplasia?

Prostate Cancer and Genetics

Single Nucleotide Polymorphisms and Prostate Cancer

Vasectomy and prostate cancer: Myth or reality?

See more featured articles »

Can Curcumin Prevent or Treat Prostate Cancer?

Gold Nanoparticles Use in Prostate Cancer

Prostate Cancer Questions

Prostate Cancer and Diet

Prostate cancer prevention

Diagnosis of Benign Prostatic Hyperplasia (BPH)

Prostate Cancer Partin Tables

Choosing the best treatment of prostate cancer - by stage

Precancerous conditions of the prostate

What is the PSA Test?

Causes of prostatitis

Prostate Cancer Symptoms

Symptoms of Benign Prostatic Hyperplasia (BHP)

Hormonal therapy for prostate cancer

Causes of benign prostatic hyperplasia

PSA Test in Men Who Have Been Treated for Prostate Cancer

Should MRI be Used to Diagnose Prostate Cancer?

What is Prostatectomy?

Prostate cancer alternative and complementary therapies

Prostate Cancer Cell Dormancy and Activation

What Should You Avoid Before a PSA Test?

Prostate Cancer Staging

Palliative treatment and end of life care for prostate cancer

Survival rates of prostate cancer

What is medical castration?

PSA False Positive and False Negative Results

Prostate cancer complications

Prostate Cancer Screening

Prostate Cancer Treatment

Radiation therapy for prostate cancer

Prostate Cancer Research

Recent Genetic Breakthroughs in Prostate Cancer Research

The Prostate

Cryosurgery for prostate cancer

Prostate Cancer Epidemiology Worldwide

Prostatitis symptoms

Breakthroughs in Prostate Cancer Treatments

Treatment of prostatitis

Prostate Biopsy

Brachytherapy for Prostate Cancer

Treatment of Benign Prostatic Hyperplasia (BHP)

What is the PCA3 Test?

Diagnosis of prostatitis

Prostate Cancer Diagnosis

What is TURP?

Rectal Examination for Prostate Cancer

What is the Gleason Score?

Differentiating between prostate cancer and prostate enlargement

Prostate Cancer Risk Factors

Latest Prostate Cancer News and Research

Low baseline testosterone predicts aggressive prostate cancer progression risk

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a more aggressive form while under active surveillance.

10 Mar 2026

FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center.

10 Mar 2026

Taking anticoagulants alongside prostate cancer drugs does not increase bleeding risk

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of anticoagulants, investigators found no evidence of an increase in patients' bleeding or clotting risks, despite previous lab results that raised alarms.

9 Mar 2026

Even patients are shocked by the prices their insurers will pay — and it costs all of us

Samantha Smith of Harrisburg, Pennsylvania, went into the operating room for emergency removal of an ectopic pregnancy.

3 Mar 2026

Global breast cancer burden rising fastest in low-income countries

Despite recent advancements in breast cancer treatments, new breast cancer cases in women are predicted to rise by a third globally from 2.3 million in 2023 to more than 3.5 million in 2050.

2 Mar 2026

Serial liquid biopsies reveal evolution in advanced prostate cancer

A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that androgen receptor (AR) alterations consistently emerged and were linked to poorer outcomes across therapies.

26 Feb 2026

Combination therapy may help overcome barrier in early-stage prostate cancer treatment

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.

26 Feb 2026

Democrats decry meager medical care for detainees in funding fight

Fernando Viera Reyes needed a biopsy for possible prostate cancer when the Trump administration sent him to an immigration detention center in California's Mojave Desert.

25 Feb 2026

New EANM award supports alpha radioligand therapy research

Applications are now open for the 2026 EANM Young Scientist Network Award. This new research award, supported by Advanced Accelerator Applications (a Novartis company), aims to accelerate innovative research in alpha radioligand therapy (α-RLT) in prostate cancer.

23 Feb 2026

Ochsner MD Anderson Cancer Center delivers Louisiana’s first TIL therapy for melanoma

Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans announces a milestone in advanced cancer treatment, as the first institution in Louisiana to provide an adult patient with tumor-infiltrating lymphocytes (TIL) therapy for advanced melanoma.

23 Feb 2026

Study finds microplastics in most prostate tumors

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.

23 Feb 2026

Smarter timing of cancer treatments could improve cure rates, study suggests

A new study provides hope that smarter timing of cancer treatments could improve cure rates.

20 Feb 2026

Remote-controlled CAR T cells offer safer cancer therapy

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells have already transformed the treatment of blood cancers.

19 Feb 2026

Researchers discover a way to breach cancer’s impenetrable fortress

Researchers at Case Western Reserve University have discovered a way to breach one of cancer's most stubborn defenses: the impenetrable fortress that solid tumors build around themselves.

18 Feb 2026

Time of radiotherapy influences cancer treatment response

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.

13 Feb 2026